APOA1 and cardiovascular disorder: In addition, the increase of HDL/ApoA1 in plasma can prevent the progression of diabetes (58), nervous system disease (59), and inflammation (60, 61), as well as play a protective role in atherosclerosis and related cardiovascular diseases (62, 63).